Less than a two weeks ago we expressed a bullish view for healthcare stocks to play a bit of catch up with the S&P 500 (SPX) as it approached its prior all time highs, choosing …
Continue readingBIIB
You guys know the drill here, the Nasdaq 100 (QQQ) is heavily concentrated by the top 10 holdings, making up 50% of the weight and equaling $2.75 trillion in market cap. While last Friday’s 16% rally …
Continue readingOne of the great market mysteries of the last six months has been the lack of equity volatility during an endless march to new high after new high. That’s been despite a backdrop of crashing commodity …
Continue readingHere is some generally directional, untied options activity that caught my eye during Tuesday’s trading: 1. FXE – minutes before the close the etf that tracks the Euro saw a massive put spread purchase. When the etf was …
Continue readingBack in March the biotechnology sector was hard hit hard alongside social media, solar and 3d printing. Since then, most of these sectors have recovered most of their losses from that sell-off. Which brings us …
Continue readingOur rationale for the IBB trade from 2 weeks ago was more technical than fundamental, as the etf approached the $255 resistance level after a big rally from the mid-April lows. After what looked like …
Continue readingBiotechs have been a leader throughout the 2009-2014 bull market. The weekly chart of IBB, the biotech ETF, illustrates the incredible run over the past 5 years: The ETF more than quadrupled from early 2009 …
Continue readingThe biotech sector was the talk of the town on Friday. The biotech ETF, IBB, was down almost 5%, and biotech shares led the Nasdaq and the healthcare sector lower. The Big Four, AMGN, GILD, …
Continue readingBiotech has been the leader to start 2014, with ICPT the poster boy for the sector after its 280% advance on Thursday (though down more than 30% today). I wanted to take a quick look …
Continue readingThrough all the ebbs and flows in 2013, the leaders have been pretty consistent. Biotechs, TSLA, NFLX, and social media stocks have been the big winners (I detailed the leaders in my Macro Wrap earlier …
Continue reading